The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 11,801–11,900 of 31,469
Brain insulin resistance and Alzheimer’s disease: a systematic review
Andrade, L. J. D. O., de Oliveira, L. M., Bittencourt, A. M. V., Lourenço, L. G. D. C., & de Oliveira, G. C. M. (2024) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2023-0032 · Cited by 35
Reduced adipocyte glutaminase activity promotes energy expenditure and metabolic health
Lecoutre, S., Maqdasy, S., Rizo‐Roca, D., Renzi, G., Vlassakev, I., Alaeddine, L. M., Higos, R., Jalkanen, J., Zhong, J., Zareifi, D., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01083-y · Cited by 33
Maouche, N., Meskine, D., Alamir, B., & Koceir, E.-A. (2015) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2015.07.002 · Cited by 29
Trementino, L., Michetti, G., Angeletti, A., Marcelli, G., Concettoni, C., Cardinaletti, C., Polenta, B., Boscaro, M., & Arnaldi, G. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-101347 · Cited by 28
Huang, J., Chen, L.-D., Lin, Q., Chen, G., Yu, Y., Huang, J., & Zhao, J. (2015) · The Clinical Respiratory Journal · doi:10.1111/crj.12276 · Cited by 30
A comparison between CLNA and CLA effects on body fat, serum parameters and liver composition
Miranda, J., Fernández‐Quintela, A., Macarulla, M. T., Churruca, I., García, C., Rodriguez, V. M., Simón, E., & Portillo, M. P. (2009) · Journal of Physiology and Biochemistry · doi:10.1007/bf03165966 · Cited by 29
Non‐invasive assessment of liver steatosis in non‐alcoholic fatty liver disease
Kan, H., Kimura, Y., Hyogo, H., Fukuhara, T., Fujino, H., Naeshiro, N., Honda, Y., Kawaoka, T., Tsuge, M., Hiramatsu, A., et al. (2014) · Hepatology Research · doi:10.1111/hepr.12330 · Cited by 30
Tinius, R. A., Cahill, A. G., Strand, E. A., & Cade, W. T. (2015) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2015-0316 · Cited by 29
Poncelas, M., Inserte, J., Vilardosa, Ú., Rodríguez‐Sinovas, A., Bañeras, J., Simó, R., & David Garcia-dorado, A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.04.023 · Cited by 29
A mouse model for nonalcoholic steatohepatitis
Sundaresan, S., Vijayagopal, P., Mills, N., Imrhan, V., & Prasad, C. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.08.011 · Cited by 30
Bouter, B., Geary, N., Langhans, W., & Asarian, L. (2010) · Metabolism · doi:10.1016/j.metabol.2009.11.003 · Cited by 29
The Liege Acromegaly Survey (LAS): A new software tool for the study of acromegaly
Pétrossians, P., Tichomirowa, M. A., Stevenaert, A., et al. (2012) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.05.001 · Cited by 29
Esquirol, Y., Bongard, V., Ferrières, J., Verdier, H., & Perret, B. (2012) · Chronobiology International · doi:10.3109/07420528.2012.719959 · Cited by 30
Association between Uric Acid and Metabolic Syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran
Ziaee, A., Esmailzadehha, N., Ghorbani, A., et al. (2012) · Global Journal of Health Science · doi:10.5539/gjhs.v5n1p155 · Cited by 29
Martínez, E., Martinez, E., Gonzalez-Cordon, A., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu898 · Cited by 29
McAuley, P. A., Hsu, F., Loman, K. K., Carr, J. J., Budoff, M. J., Szklo, M., Sharrett, A. R., & Ding, J. (2011) · Obesity · doi:10.1038/oby.2011.191 · Cited by 29
Tuna, M. M., Dogan, B. A., Arduç, A., İmga, N. N., Tütüncü, Y., Berker, D. S., & Güler, S. (2014) · Clinical Endocrinology · doi:10.1111/cen.12666 · Cited by 29
YIN, L., Cai, W., Chang, X., Li, J., Su, X., Zhu, L., Wang, X., & Sun, K. (2014) · Biomedical Reports · doi:10.3892/br.2014.356 · Cited by 30
Impaired β Cell Function in Chinese Newly Diagnosed Type 2 Diabetes Mellitus with Hyperlipidemia
Ma, Y., Wang, Y., Huang, Q., Ren, Q., Chen, S., Zhang, A., Zhao, L., Zhen, Q., & Peng, Y. (2014) · Journal of Diabetes Research · doi:10.1155/2014/493039 · Cited by 29
Serum complement C3 correlates with insulin resistance in never treated psoriatic arthritis patients
Ursini, F., Grembiale, A., Naty, S., & Grembiale, R. D. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2366-4 · Cited by 29
Sun, K., Lu, J., Jiang, Y., Xu, M., Xu, Y., Zhang, J., Xu, B., Sun, J., Sun, W., Ren, C., et al. (2013) · Clinical Endocrinology · doi:10.1111/cen.12168 · Cited by 29
Inflammatory Markers and Clustered Cardiovascular Disease Risk Factors in Danish Adolescents
Bugge, A., El-Naaman, B., McMurray, R. G., Froberg, K., Nielsen, C. H., Müller, K., & Andersen, L. B. (2012) · Hormone Research in Paediatrics · doi:10.1159/000345546 · Cited by 31
Sedgwick, M. J., Morris, J. G., Nevill, M. E., & Barrett, L. A. (2014) · Journal of Sports Sciences · doi:10.1080/02640414.2014.964749 · Cited by 29
Bredella, M. A., Torriani, M., Ghomi, R. H., Thomas, B. J., Brick, D. J., Gerweck, A. V., Harrington, L. M., & Miller, K. K. (2010) · Obesity · doi:10.1038/oby.2010.296 · Cited by 30
Pereira, P. F., Serrano, H. M. S., Carvalho, G. Q., Lamounier, J. A., Pelúzio, M. D. C. G., Franceschini, S. D. C. C., & Priore, S. E. (2011) · Revista Paulista de Pediatria · doi:10.1590/s0103-05822011000300011 · Cited by 32
Shimodaira, M., Niwa, T., Nakajima, K., Kobayashi, M., Hanyu, N., & Nakayama, T. (2014) · Annals of Nutrition and Metabolism · doi:10.1159/000360012 · Cited by 29
Fernández‐García, J. C., Murri, M., Coín‐Aragüez, L., Alcaide, J., Bekay, R. E., & Tinahones, F. J. (2013) · Clinical Endocrinology · doi:10.1111/cen.12221 · Cited by 30
Adiponectin and the Incidence of Type 2 Diabetes in Hispanics and African Americans
Hanley, A. J., Wagenknecht, L. E., Norris, J. M., Bergman, R. N., Anderson, A., Chen, Y. I., Lorenzo, C., & Haffner, S. M. (2011) · Diabetes Care · doi:10.2337/dc11-0531 · Cited by 29
Erdogan, M., Karadeniz, M., Berdelı, A., Alper, G. E., Çağlayan, O., & Yılmaz, C. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345614 · Cited by 29
Ma, Y., Balasubramanian, R., Pagoto, S., Schneider, K. L., Hébert, J. R., Phillips, L. S., Goveas, J. S., Culver, A. L., Olendzki, B. C., Beck, J., et al. (2013) · American Journal of Public Health · doi:10.2105/ajph.2013.301394 · Cited by 31
Kasapoğlu, B., Türkay, C., Yalçın, K. S., Çarlıoğlu, A., Sozen, M. Y., & Köktener, A. (2013) · Clinical Medicine · doi:10.7861/clinmedicine.13-6-576 · Cited by 29
Mukai, N., Doi, Y., Ninomiya, T., Hata, J., Hirakawa, Y., Fukuhara, M., Iwase, M., & Kiyohara, Y. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03378.x · Cited by 30
Circulating adipocyte fatty acid binding protein is increased in chronic and acute renal dysfunction
Ebert, T., Hopf, L., Wurst, U., Bachmann, A., Kralisch, S., Lössner, U., Platz, M., Kratzsch, J., Stolzenburg, J. ‐., Dietel, A., et al. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.03.006 · Cited by 29
Sex-Specific Differences in an ApoE−/−:Ins2+/Akita Mouse Model of Accelerated Atherosclerosis
Venegas-Pino, D. E., Wang, P., Stoute, H., Pickersgill, N. A., Hong, B. Y., Khan, M. I., Shi, Y., & Werstuck, G. H. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.09.009 · Cited by 30
Hong, S. B., Lee, J. J., Kim, S. H., Suh, Y. J., Han, J. Y., Kim, Y., & Nam, M. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.10.017 · Cited by 29
Sasaki, Y., Kohjimoto, Y., Iba, A., Matsumura, N., & Hara, I. (2015) · International Journal of Urology · doi:10.1111/iju.12691 · Cited by 29
Zając-Gawlak, I., Pośpiech, D., Kroemeke, A., Mossakowska, M., Gába, A., Pelclová, J., Přidalová, M., & Kłapcińska, B. (2016) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2016.01.008 · Cited by 32
Escobar-Morreale, H. F., Martínez-García, M. Á., Montes‐Nieto, R., Fernández‐Durán, E., Temprano‐Carazo, S., & Luque‐Ramírez, M. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.01.015 · Cited by 29
González-Mejía, M. E., Porchia, L. M., Torres‐Rasgado, E., Ruiz‐Vivanco, G., Pulido‐Perez, P., Báez-Duarte, B. G., & Pérez-Fuentes, R. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0067 · Cited by 29
Kim, M., Song, G., Kang, M., et al. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0063-4 · Cited by 29
Webb, R., Thompson, J. E. S., Ruffino, J. S., Davies, N. A., Watkeys, L. J., Hooper, S. J., Jones, P. M., Walters, G., Clayton, D., Thomas, A. W., et al. (2016) · BMJ Open Sport & Exercise Medicine · doi:10.1136/bmjsem-2015-000089 · Cited by 29
EFFECTS OF OATS ON LIPID PROFILE, INSULIN RESISTANCE AND WEIGHT LOSS.
Schuster, J., Benincá, G., Vitorazzi, R., et al. (2015) · PubMed · doi:10.3305/nh.2015.32.5.9590 · Cited by 29
Kim, L.-K., Yoon, J. W., Lee, D., Kim, K. M., Choi, S. H., Park, K. S., Jang, H. C., Kim, M.-K., Park, H. E., Choi, S., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0404-7 · Cited by 29
Gradidge, P. J.-L., Norris, S. A., Jaff, N. G., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162247 · Cited by 29
Lontchi‐Yimagou, E., Nguewa, J. L., Assah, F. K., Noubiap, J. J., Boudou, P., Djahmeni, E. N., Balti, E. V., Atogho‐Tiedeu, B., Gautier, J., Mbanya, J. C., et al. (2016) · Diabetic Medicine · doi:10.1111/dme.13264 · Cited by 29
Oh, J. Y., Allison, M., & Barrett-Connor, E. L. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001145 · Cited by 29
Chung, T., Kwon, Y., Shim, J., & Lee, Y. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.10.032 · Cited by 30
Díaz‐Rúa, R., Palou, A., & Oliver, P. (2016) · Food & Nutrition Research · doi:10.3402/fnr.v60.33554 · Cited by 29
Koç, Ö., Ozdemirici, S., Acet, M., Soyturk, U., & Aydın, S. (2017) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2017.1315563 · Cited by 31
Predictors of Independent Aging and Survival: A 16‐Year Follow‐Up Report in Octogenarian Men
Franzon, K., Byberg, L., Sjögren, P., Zethelius, B., Cederholm, T., & Kilander, L. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14971 · Cited by 29
Geetha, R., Priya, C. S., & Anuradha, C. V. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.09.012 · Cited by 29
Insulin resistance and bone age advancement in girls with central precocious puberty
Hur, J. H., Park, S., Jung, M. K., Kang, S. J., Kwon, A., Chae, H. W., Kim, H.-S., & Kim, D. H. (2017) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2017.22.3.176 · Cited by 30
Leopoldia comosa prevents metabolic disorders in rats with high-fat diet-induced obesity
Casacchia, T., Scavello, F., Rocca, C., Granieri, M. C., Beretta, G., Amelio, D., Gelmini, F., Spena, A. R., Mazza, R., Toma, C. C., et al. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1609-1 · Cited by 30
Bonafini, S., Tagetti, A., Gaudino, R., Cavarzere, P., Montagnana, M., Danese, E., Benati, M., Ramaroli, D. A., Raimondi, S., Giontella, A., et al. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1677-2 · Cited by 29
Rosenbaum, M. S., Agurs‐Collins, T., Bray, M. S., Hall, K. D., Hopkins, M., Laughlin, M. R., MacLean, P. S., Maruvada, P., Savage, C. R., Small, D. M., et al. (2018) · Obesity · doi:10.1002/oby.22156 · Cited by 31
Goss, M. J., Nunes, M. L., Machado, I. D., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.137 · Cited by 29
Gholinezhad, M., Gholsorkhtabaramiri, M., Esmaeilzadeh, S., & Ghanbarpour, A. (2018) · Europe PMC (PubMed Central) · doi:10.22088/cjim.9.3.260 · Cited by 29
Branched-chain amino acids are associated with metabolic parameters in bipolar disorder
Fellendorf, F. T., Platzer, M., Pilz, R., Rieger, A., Kapfhammer, H., Mangge, H., Dalkner, N., Zelzer, S., Meinitzer, A., Birner, A., et al. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1487077 · Cited by 29
Alshareef, S. A., Rayis, D. A., Adam, I., & Gasim, G. I. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3642-9 · Cited by 29
Wong, Q. H. Y., Li, R., Lam, K. S. L., Tam, S., Shek, C. C., Lee, C. Y. V., Yeung, W. S. B., Ho, P. C., & Ng, E. H. Y. (2018) · Clinical Endocrinology · doi:10.1111/cen.13816 · Cited by 29
Mehanna, E. T., El-Sayed, N. M., Ibrahim, A. K., Ahmed, S. A., & Abo–Elmatty, D. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.126 · Cited by 28
Ezeh, U. I., Chen, Y. I., Chen, Y., & Azziz, R. (2019) · Clinical Endocrinology · doi:10.1111/cen.13931 · Cited by 29
Mahmassani, Z. S., Reidy, P. T., McKenzie, A. I., Stubben, C., Howard, M. T., & Drummond, M. J. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01093.2018 · Cited by 29
Xepapadaki, E., Maulucci, G., Constantinou, C., Karavia, E. A., Zvintzou, E., Daniel, B., Sasson, S., & Kypreos, K. E. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.02.003 · Cited by 29
Gujral, U. P., Prabhakaran, D., Pradeepa, R., Kandula, N. R., Kondal, D., Deepa, M., Zakai, N. A., Anjana, R. M., Rautela, G., Mohan, V., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.05.026 · Cited by 31
Mora‐Rodríguez, R., ORTEGA, J. F., Ramírez-Jiménez, M., Moreno‐Cabañas, A., & Morales‐Palomo, F. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.05.004 · Cited by 30
Adikaram, S. G. S., Samaranayake, D. B. D. L., Atapattu, N., Kendaragama, K. M. D. L. D., Senevirathne, J. T. N., & Wickramasinghe, P. (2019) · BMC Pediatrics · doi:10.1186/s12887-019-1558-8 · Cited by 29
Mourelatou, R., Kostopoulou, E., Gil, A. P. R., Kehagias, I., Linos, D., Kalfarentzos, F. E., & Spiliotis, B. E. (2019) · HORMONES · doi:10.1007/s42000-019-00130-8 · Cited by 30
Rancourt-Bouchard, M., Gigleux, I., Guay, V., Charest, A., Saint-Gelais, D., Vuillemard, J.-C., Lamarche, B., & Couture, P. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz251 · Cited by 29
Zhong, L.-X., Li, X.-N., Yang, G., Zhang, X., Li, W., Zhang, Q.-Q., Pan, H.-X., Zhang, H.-H., Zhou, M., Wang, Y., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225813 · Cited by 32
Sharif‐Askari, F. S., Sharif‐Askari, N. S., Halwani, R., Abusnana, S., Hamoudi, R., & Sulaiman, N. D. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s245742 · Cited by 29
Rodríguez, G. L., Estrada-Neria, A., Suárez-Diéguez, T., Tejero, M. E., Fernández-López, J. C., & Galván, M. (2020) · Gene · doi:10.1016/j.gene.2020.144840 · Cited by 34
Lai, S., Mazzaferro, S., Muscaritoli, M., et al. (2020) · Toxins · doi:10.3390/toxins12060381 · Cited by 29
Ilievski, V., Tóth, P. T., Valyi‐Nagy, K., Vályi-Nagy, T., Green, S. J., Marattil, R. S., Aljewari, H. W., Wicksteed, B. L., O’brien-simpson, N. M., Reynolds, E. C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-65828-x · Cited by 35
Kazemi, M., Jarrett, B. Y., Parry, S. A., Thalacker‐Mercer, A. E., Hoeger, K. M., Spandorfer, S. D., & Lujan, M. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa426 · Cited by 29
Karras, S. Ν., Koufakis, T., Adamidou, L., Pοlyzos, S. A., Karalazou, P., Thisiadou, K., Zebekakis, P. E., Makedou, K., & Kotsa, K. (2020) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2020.1787959 · Cited by 29
Abd-Allah, H., Nasr, M., Ahmed-Farid, O. A.-H., Ibrahim, B. M. M., Bakeer, R. M., & Ahmed, R. F. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118540 · Cited by 29
Bullón‐Vela, V., Abete, I., Tur, J. A., Konieczna, J., Romaguera, D., Pintó, X., Corbella, E., Martínez‐González, M. Á., Sayón-Orea, C., Toledo, E., et al. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820958298 · Cited by 31
Behrooz, M., Vaghef‐Mehrabany, E., Moludi, J., & Ostadrahimi, A. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108634 · Cited by 29
Lamarca, F., Vieira, F. T., Lima, R. M., Nakano, E. Y., da Costa, T. H. M., Pizato, N., Dutra, E. S., & de Carvalho, K. M. B. (2021) · Obesity Surgery · doi:10.1007/s11695-020-05172-1 · Cited by 34
Expression and clinical significance of miR‑1 and miR‑133 in pre‑diabetes
Al‐Kafaji, G., Al-Muhtaresh, H. A., & Salem, A. H. (2021) · Biomedical Reports · doi:10.3892/br.2021.1409 · Cited by 30
el-Din, S. H. S., Salem, M., El-Lakkany, N. M., Hammam, O. A., Nasr, S. M., Okasha, H., Ahmed, L. N., Saleh, S., & Botros, S. S. (2021) · Human & Experimental Toxicology · doi:10.1177/0960327121999445 · Cited by 30
Watanabe, J., Hashimoto, N., Yin, T., Sandagdorj, B., Arakawa, C., Inoue, T., & Suzuki, S. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.15079 · Cited by 30
Hashem, M. A., Abd-Allah, N. A., Mahmoud, E. A., et al. (2021) · Biology · doi:10.3390/biology10040335 · Cited by 29
Semnani-Azad, Z., Mejia, S. B., Connelly, P., Bazinet, R., Retnakaran, R., Jenkins, D., Harris, S., & Hanley, A. (2021) · Obesity Reviews · doi:10.1111/obr.13257 · Cited by 26
Metabolic syndrome and Growth Differentiation Factor 15 in older adults
Carballo‐Casla, A., García‐Esquinas, E., Soto, A. B., Struijk, E. A., López‐García, E., Rodríguez‐Artalejo, F., & Ortolá, R. (2021) · GeroScience · doi:10.1007/s11357-021-00370-w · Cited by 29
Mostafa, T. M., El-Gharbawy, N. M., & Werida, R. H. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.05.003 · Cited by 29
Fridolfsson, J., Buck, C., Hunsberger, M. L., Baran, J., Lauria, F., Molnár, D., Moreno, L. A., Börjesson, M., Lissner, L., & Arvidsson, D. (2021) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-021-01156-1 · Cited by 29
Lin, Y., Wu, J., Zhu, Y., Hinkle, S. N., Rawal, S., Liang, L., Weir, N. L., Tsai, M. Y., & Zhang, C. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.07.008 · Cited by 29
Kobayashi, Y., Eguchi, A., Tamai, Y., Fukuda, S., Tempaku, M., Izuoka, K., Iwasa, M., Takei, Y., & Togashi, K. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.693007 · Cited by 30
Association Analysis of Insulin Resistance and Osteoporosis Risk in Chinese Patients with T2DM
Wang, X., Jiang, L., & Shao, X. (2021) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s328510 · Cited by 30
Liu, F., Sirisena, S., & Ng, K. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.2009761 · Cited by 29
Coriander Oil Reverses Dexamethasone-Induced Insulin Resistance in Rats
Mahmoud, M. F., Ali, N., Mostafa, I., Hasan, R. A., & Sobeh, M. (2022) · Antioxidants · doi:10.3390/antiox11030441 · Cited by 30
Dieli-Conwright, C. M., Wong, L. C., Waliany, S., & Mortimer, J. E. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00807-y · Cited by 29
Kim, Y., Chang, Y., Ryu, S., Wild, S. H., & Byrne, C. D. (2021) · Hepatology · doi:10.1002/hep.32560 · Cited by 29
Alsuliam, S. M., Albadr, N. A., Almaiman, S. A., et al. (2022) · Toxics · doi:10.3390/toxics10070362 · Cited by 29
Dynamics of thyroid diseases and thyroid‐axis gland masses
Kohanim, Y. K., Milo, T., Raz, M., Karin, O., Bar, A., Mayo, A., Cohen, N. M., Toledano, Y., & Alon, U. S. (2022) · Molecular Systems Biology · doi:10.15252/msb.202210919 · Cited by 29
Comparison of triglyceride glucose index and HbA1C as a marker of prediabetes – A preliminary study
An, V. D., Rajput, R., Meena, M., Mohini, M., Garg, R. K., & Saini, S. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102605 · Cited by 29
Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China
Wang, Y., Yu, Y.-T., Zhang, H., Chen, C., Wan, H., Chen, Y., Xia, F., Yu, S., Wang, N., Ye, L., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.968766 · Cited by 31
Sasaki, N., Maeda, R., Ozono, R., Yoshimura, K., Nakano, Y., & Higashi, Y. (2022) · Hypertension Research · doi:10.1038/s41440-022-00987-0 · Cited by 33
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
